SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-074871
Filing Date
2024-06-25
Accepted
2024-06-25 21:03:08
Documents
1
Period of Report
2024-06-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2418256-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2418256-1_3seq1.xml 3 1589
  Complete submission text file 0001104659-24-074871.txt   3384
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4264 CORTE FAVOR SAN DIEGO CA 92130
Business Address
HARTOUNIAN HARTOUN (Reporting) CIK: 0001214476 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36641 | Film No.: 241070399